DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Actigall (Ursodiol) - Summary

 

-- advertisement --

ACTIGALL SUMMARY

Actigall is a bile acid available as 300-mg capsules suitable for oral administration. Actigall is ursodiol USP (ursodeoxycholic acid), a naturally occurring bile acid found in small quantities in normal human bile and in the biles of certain other mammals. It is a bitter-tasting, white powder freely soluble in ethanol, methanol, and glacial acetic acid; sparingly soluble in chloroform; slightly soluble in ether; and insoluble in water.

  1. Actigall is indicated for patients with radiolucent, noncalcified gallbladder stones < 20 mm in greatest diameter in whom elective cholecystectomy would be undertaken except for the presence of increased surgical risk due to systemic disease, advanced age, idiosyncratic reaction to general anesthesia, or for those patients who refuse surgery. Safety of use of Actigall beyond 24 months is not established.

  2. Actigall is indicated for the prevention of gallstone formation in obese patients experiencing rapid weight loss.

ACTIGALL NEWS HIGHLIGHTS

Media Articles Related to Actigall (Ursodiol)

Primary Biliary Cirrhosis
Source: MedicineNet ursodiol Specialty [2005.09.17]

more>>

Published Studies Related to Actigall (Ursodiol)

Clinical Trial: Randomized controlled trial of zidovudine and lamivudine for patients with primary biliary cirrhosis stabilized on ursodiol. [2008.07.09]

Ursodiol in patients with parenteral nutrition-associated cholestasis. [2007.11]

Ursodiol in Patients with Parenteral Nutrition-Associated Cholestasis (November). [2007.10.02]

Ursodiol use is possibly associated with lower incidence of hepatocellular carcinoma in hepatitis C virus-associated liver cirrhosis. [2005.01]

more>>

Clinical Trials Related to Actigall (Ursodiol)

Ursodiol in Huntington's Disease [Recruiting]

Trial of High-Dose Urso in Primary Sclerosing Cholangitis [Completed]

Ursodeoxycholic Acid in the Treatment of Duodenal Adenomas in Familial Adenomatous Polyposis (FAP) Patients [Completed]

Efficacy and Safety Study of Ursodeoxycholic Acid to Treat Chronic Hepatitis C [Completed]

Pilot Study of Ursodesoxycholic Acid in Non-Alcoholic Steatohepatitis [Recruiting]

more>>

Page last updated: 2008-08-10

-- advertisement -- The American Red Cross

We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2008